In this study, the effect of chronic administration of melatonin on MRL/MpJ-Fas(lpr) mice has been studied. These mice spontaneously develop an autoimmune disease that has many features resembling human systemic lupus erythematosus. In fact, histological studies showed that all female mice and most male mice exhibited glomerular abnormalities, arteritic lesions, and cellular interstitial inflammatory infiltrate ranging from mild to severe patterns. Treatment with melatonin improved the histological pattern in females and worsened it in males. Moreover, female mice treated with melatonin showed a diminution of titers of total serum IgG, IgM, and anti-double-stranded DNA and anti-CII autoantibodies; a decrease in proinflammatory cytokines (IL-2, IL-6, interferon-gamma, TNF-alpha, and IL-1beta), an increase in antiinflammatory cytokines (IL-10), and a decrease in nitrite/nitrate. In male mice, treatment with melatonin exhibited the opposite effect, worsening all the immunological parameters with an elevation of titers of autoantibodies and a prevalence of proinflammatory vs. antiinflammatory cytokines. Similar results were obtained when lymphocytes from spleen and lymph nodes were cultured. Again, melatonin treatment in females decreased proinflammatory cytokines and increased antiinflammatory cytokines produced by lymphocytes; in males, the effect was the opposite. These findings suggest that melatonin action in MRL/MpJ-Fas(lpr) mice is gender dependent, probably through modulation and inhibition of sex hormones.

Download full-text PDF

Source
http://dx.doi.org/10.1210/en.2005-0648DOI Listing

Publication Analysis

Top Keywords

mrl/mpj-faslpr mice
12
antiinflammatory cytokines
12
mice
8
female mice
8
male mice
8
treatment melatonin
8
proinflammatory cytokines
8
melatonin
6
cytokines
5
sex-dependent melatonin
4

Similar Publications

Deficiency of the V-domain immunoglobulin suppressor of T-cell activation (VISTA) accelerates disease progression in lupus-prone mice, and activation of VISTA shows therapeutic effects in mouse models of a lupus-like disease. Metabolic reprogramming of T cells in systemic lupus erythematosus (SLE) patients is important in regulating T-cell function and disease progression. However, the mechanism by which VISTA affects the immunometabolism in SLE remains unclear.

View Article and Find Full Text PDF

Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by self-antibody production and widespread inflammation affecting various body tissues. This disease is driven by the breakdown of immune tolerance, which promotes the activation of autoreactive B and T cells. A key feature of SLE is dysregulation in antigen presentation, where antigen-presenting cells (APCs) play a central role in perpetuating immune responses.

View Article and Find Full Text PDF

WIF-1 contributes to lupus-induced neuropsychological deficits via the CRYAB/STAT4-SHH axis.

Arthritis Res Ther

October 2024

The State Key Laboratory of Pharmaceutical Biotechnology, Division of Immunology, Medical School, Nanjing University, Nanjing, 210093, China.

Article Synopsis
  • Neuropsychiatric systemic lupus erythematosus (NPSLE) leads to cognitive decline, with activated microglia and disrupted blood-brain barrier (BBB) being key factors, and WIF-1 (a secreted protein) is found in the cerebrospinal fluid of affected patients.
  • Research using lupus-prone mice reveals that injecting WIF-1 worsens cognitive and mood issues, increases BBB leakage, and causes abnormal microglial activation, while reducing WIF-1 shows improvement in symptoms.
  • The study suggests that WIF-1 contributes to cognitive dysfunction through a specific pathway (CRYAB/STAT4-SHH), and indicates that symmetric dimethylarginine (SDMA) can
View Article and Find Full Text PDF

Effect of Spermidine on Endothelial Function in Systemic Lupus Erythematosus Mice.

Int J Mol Sci

September 2024

Department of Kinesiology and Sport Management, Texas Tech University, Lubbock, TX 79409, USA.

Endothelial dysfunction is common in Systemic Lupus Erythematosus (SLE), even in the absence of cardiovascular disease. Evidence suggests that impaired mitophagy contributes to SLE. Mitochondrial dysfunction is also associated with impaired endothelial function.

View Article and Find Full Text PDF

CS12192, a novel JAK3/JAK1/TBK1 inhibitor, attenuates autoimmune dermatoses in murine models.

Immunopharmacol Immunotoxicol

August 2024

Chengdu Chipscreen Pharmaceutical Ltd, Chengdu, Sichuan, China.

Objective: Autoimmune dermatosis (AID) occurs when the body's immune system attacks skin or tissue, leading to various types of skin disorders or injuries. Recent studies show that Janus kinases (JAKs) play critical roles in autoimmune diseases including AID by regulating multiple cytokine signaling pathways. CS12192, a novel JAK3/JAK1/TBK1 inhibitor, has been reported to exert ameliorative effects in rheumatoid arthritis.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!